PB2119: REDUCED OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS DURING THE COVID-19 PANDEMIC

PB2119: REDUCED OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS DURING THE COVID-19 PANDEMIC

Bibliographic Details
Main Authors:	Alexander Luchinin, Elena Osipova, Natalia Minaeva
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000975248.48085.0f

Similar Items

Real-world assessment of treatment multiple myeloma patients on the example of one hematology center
by: A. S. Luchinin, et al.
Published: (2023-10-01)

Museum of marine life 2119
by: Bao, Songyu
Published: (2019)

EPIDEMIOLOGY OF MULTIPLE MYELOMA ACCORDING TO THE КIROV REGION POPULATION REGISTERS
by: A. S. Luchinin, et al.
Published: (2017-10-01)

PB2119: LONG-TERM SURVIVAL PROJECTIONS OF LONCASTUXIMAB TESIRINE-TREATED PATIENTS IN RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
by: M. Hamadani, et al.
Published: (2022-06-01)

Application of bioparticle in biofilter (PI 2006 2119) for watewater treatment /
by: Nadirah Ismail, author, et al.
Published: (2008)

PB2093: OVERALL SURVIVAL IN RELAPSED-REFRACTORY MYELOMA PATIENTS DEPENDS ON CIRCULATING PLASMA CELLS QUANTITATION
by: Nunziatina Laura Parrinello, et al.
Published: (2023-08-01)

Body Mass Index and Overall Survival of Patients with Newly Diagnosed Multiple Myeloma
by: Bei Wang, et al.
Published: (2022-10-01)

THE EFFECT OF BISPHOSPHONATE USE ON TREATMENT RESPONSE AND OVERALL SURVIVAL IN MULTIPLE MYELOMA PATIENTS
by: Ayşe Uysal, et al.
Published: (2021-11-01)

Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population.
by: Rasmus Sørrig, et al.
Published: (2017-01-01)

Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients.
by: Rebmann, V, et al.
Published: (2007)

COMPREHENSIVE CIRCRNA ANALYSIS REVEALS MOLECULAR INTERACTIONS RELATED TO POOR OVERALL SURVIVAL IN MULTIPLE MYELOMA
by: LRD Merces, et al.
Published: (2023-10-01)

Kamienie w fundamentach Nowego Jeruzalem – analiza obrazu Ap 21,19-20
by: Joanna Nowińska
Published: (2017-05-01)

The Effects of Second Primary Malignancies and Frailty on Overall Survival and Mortality in Geriatric Turkish Patients with Multiple Myeloma
by: Yildiz Ipek, et al.
Published: (2023-06-01)

Predictive Value of the Hematopoietic Stem Cell Transplantation - Comorbidity Index for Overall Survival in Patients with Multiple Myeloma
by: Tayfun Elibol, et al.
Published: (2022-11-01)

A Precisely Calculated Neutrophil to Lymphocyte Ratio could Predict Overall Survival in Multiple Myeloma Patients
by: Hasan Jalaeikhoo, et al.
Published: (2018-07-01)

NAIRscore as a biomarker for the quality of immune response to neoantigens is related with an increased overall survival in multiple myeloma
by: Xingxing Jian, et al.
Published: (2022-09-01)

Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma
by: Ga-Young Song, et al.
Published: (2020-08-01)

Application of clinical nomograms to predicting overall survival and event-free survival in multiple myeloma patients: Visualization tools for prognostic stratification
by: Jiaxuan Xu, et al.
Published: (2022-10-01)

PB2108: SPINAL INVOLVEMENT IS ASSOCIATED WITH HIGH INCIDENCE OF SKELETAL RELATED EVENTS AND INFERIOR OVERALL SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA. A SINGLE CENTRE EXPERIENCE IN 653 PATIENTS.
by: Nikolaos Kanellias, et al.
Published: (2023-08-01)

PB2081: CYTOGENETICS OF MULTIPLE MYELOMA IN MOROCCO
by: Yasmine Moutmir, et al.
Published: (2023-08-01)

Super-Enhancer Associated Five-Gene Risk Score Model Predicts Overall Survival in Multiple Myeloma Patients
by: Tingting Qi, et al.
Published: (2020-12-01)

Management of multiple myeloma during COVID-19 pandemic
by: YS Jethava, et al.
Published: (2020-01-01)

Machine Learning–Based Overall Survival Prediction of Elderly Patients With Multiple Myeloma From Multicentre Real-Life Data
by: Li Bao, et al.
Published: (2022-06-01)

SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE
by: Stergios Intzes, et al.
Published: (2021-01-01)

KD025 (SLx-2119) suppresses adipogenesis at intermediate stage in human adipose-derived stem cells
by: Duy Trong Vien Diep, et al.
Published: (2019-01-01)

3 years survival of patients with multiple myeloma.
by: Julio Dámaso Fernández Águila, et al.
Published: (2006-12-01)

3 years survival of patients with multiple myeloma.
by: Julio Dámaso Fernández Águila, et al.
Published: (2006-12-01)

PB2157: AUTOSCT IN PATIENTS WITH MULTIPLE MYELOMA AND DIALYSIS-DEPENDENT NEPHROPATHY
by: Ekaterina Karimova, et al.
Published: (2023-08-01)

ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE VERSUS CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA (IKEMA): FINAL OVERALL SURVIVAL ANALYSIS
by: Ecenur Guder Arslan, et al.
Published: (2023-10-01)

Development and Validation of a Novel Prognostic Model for Overall Survival in Newly Diagnosed Multiple Myeloma Integrating Tumor Burden and Comorbidities
by: Shuangshuang Jia, et al.
Published: (2022-03-01)

Application of the cost-effectiveness method in improving the pharmacotherapy of multiple myeloma
by: E. A. Luchinin, et al.
Published: (2023-04-01)

Analyses of canine cancer mutations and treatment outcomes using real-world clinico-genomics data of 2119 dogs
by: Kevin Wu, et al.
Published: (2023-01-01)

TOI-2119: A transiting brown dwarf orbiting an active M-dwarf from NASA’s TESS mission
by: Seager, Sara
Published: (2023)

PB1975: THE RESEARCH ON THE MECHANISM OF RRAD GENE IN MULTIPLE MYELOMA
by: C. Yi, et al.
Published: (2022-06-01)

PB1974: MULTIVARIATE SPECTRAL BIOTYPING OF EXTRAMEDULLARY MULTIPLE MYELOMA
by: M. Vlachová, et al.
Published: (2022-06-01)

PB2278: INVESTIGATION ON THE STATUS OF INFECTION IN PATIENTS WITH MULTIPLE MYELOMA
by: D. Lan, et al.
Published: (2022-06-01)

PB1990: MULTIPLE MYELOMA IN THE ELDERLY: A MONOCENTRIC EXPERIENCE
by: H. Charfi, et al.
Published: (2022-06-01)

PB1981: EFFICACY AND SAFETY OF DENOSUMAB IN PATIENTS WITH MULTIPLE MYELOMA
by: S. Bougherira, et al.
Published: (2022-06-01)

PB1969: FUNCTIONAL CHARACTERIZATION OF SUSCEPTIBILITY LOCI TO MULTIPLE MYELOMA
by: M. Shokouhi, et al.
Published: (2022-06-01)

Pretreatment Serum Levels of IL-1 Receptor Antagonist and IL-4 Are Predictors of Overall Survival in Multiple Myeloma Patients Treated with Bortezomib
by: Damian Mikulski, et al.
Published: (2021-12-01)